{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:29:38Z","timestamp":1786350578506,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["10330022010009"],"award-info":[{"award-number":["10330022010009"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Dutch Ministry of Health, Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hodgkin lymphoma (HL) survivors are at increased risk of late adverse events, eg, cardiovascular diseases (CVD), breast cancer (BC), hypothyroidism and severe infections. At Dutch BETER clinics, HL survivors are regularly screened for (risk factors for) these adverse events. The impact of survivorship care on the burden of disease from adverse outcomes has rarely been evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a nationwide retrospective cohort study, we compared HL survivors invited for BETER care in 2013-2016 (intervention group) with matched survivors who were eligible for such care but were not invited until 2019-2024 (comparison group). Incidence and mortality rates for CVD, BC, hypothyroidism, and severe infections were collected from general practitioners and nationwide registries. Disability-adjusted life years (DALYs) attributable to late adverse events were compared using multivariable regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At study start, survivors in the intervention group (n\u2009=\u2009491) and comparison group (n\u2009=\u2009373) had a median age of 46\u2009years; median time since HL diagnosis was 15-18\u2009years. After 8.5\u2009years (median), there were no significant differences in DALYs attributable to CVD, BC, hypothyroidism, and severe infections between the groups. In both groups, approximately one third of survivors acquired DALYs attributable to adverse events. Adherence to recommended screening diagnostics was high, but cardiovascular risk management and vaccination rates were suboptimal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After 8.5\u2009years of follow-up, survivorship care for HL survivors was not associated with lower disease burden. Better care coordination, amendment of the cardiovascular risk management guidelines, and greater survivor involvement may improve long-term effectiveness of measures to prevent late adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag080","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:42:41Z","timestamp":1775821361000},"page":"1514-1526","source":"Crossref","is-referenced-by-count":2,"title":["The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-3500","authenticated-orcid":false,"given":"Eline M J","family":"Lammers","sequence":"first","affiliation":[{"name":"Department of Epidemiology, The Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e M","family":"Zijlstra","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-7182","authenticated-orcid":false,"given":"Michael","family":"Schaapveld","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita A","family":"Haagsma","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center , Rotterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile P M","family":"Janus","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Erasmus University Medical Center , Rotterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M","family":"Aarsman","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Utrecht , Utrecht,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liane C J te","family":"Boome","sequence":"additional","affiliation":[{"name":"Department of Hematology, Haaglanden Medical Center , Leidschendam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike M G","family":"Schippers","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute Verbeeten , Tilburg,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinske S","family":"Boersma","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amphia hospital , Breda,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9590-9667","authenticated-orcid":false,"given":"Saskia E","family":"Rademakers","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Leiden University Medical Center , Leiden,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J","family":"Plattel","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Groningen , Groningen,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara H","family":"B\u00f6hmer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Haga hospital , The Hague,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van Den Berg","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catharina hospital , Eindhoven,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaantje C","family":"Kroeze","sequence":"additional","affiliation":[{"name":"Department of Hematology, Meander Medical Center , Amersfoort,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie S","family":"Strobbe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Gelre hospitals , Zutphen and Apeldoorn,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Deenik","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rijnstate hospital , Arnhem,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen S","family":"de Lil","sequence":"additional","affiliation":[{"name":"Department of Hematology, M\u00e1xima Medical Center , Eindhoven and Veldhoven,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthe M P","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-1484","authenticated-orcid":false,"given":"Flora E","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-5164","authenticated-orcid":false,"given":"Annelies","family":"Nijdam","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"2026081003524966800_djag080-B1","author":"Netherlands Cancer Registry. Hodgkin lymphoma"},{"key":"2026081003524966800_djag080-B2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nrclinonc.2012.91","article-title":"State of the art in the treatment of Hodgkin lymphoma","volume":"9","author":"Borchmann","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"2026081003524966800_djag080-B3","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"2026081003524966800_djag080-B4","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","article-title":"Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin\u2019s lymphoma in England and Wales: a National Cohort Study","volume":"30","author":"Swerdlow","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026081003524966800_djag080-B5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"2026081003524966800_djag080-B6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin\u2019s disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N Engl J Med"},{"key":"2026081003524966800_djag080-B7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/jnci\/djaa194","article-title":"Long-term cause-specific mortality in Hodgkin lymphoma patients","volume":"113","author":"de Vries","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026081003524966800_djag080-B8","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1111\/bjh.15936","article-title":"Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma","volume":"186","author":"Nijdam","year":"2019","journal-title":"Br J Haematol"},{"key":"2026081003524966800_djag080-B9","author":"Dutch Society for Radiation Therapy and Oncology (NVRO)"},{"key":"2026081003524966800_djag080-B10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.7326\/M13-2266","article-title":"Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects","volume":"160","author":"Yeh","year":"2014","journal-title":"Ann Intern Med"},{"key":"2026081003524966800_djag080-B11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7326\/M13-2498","article-title":"Cost-effectiveness of the Children\u2019s Oncology Group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure","volume":"160","author":"Wong","year":"2014","journal-title":"Ann Intern Med"},{"key":"2026081003524966800_djag080-B12","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1200\/JCO.2009.22.8460","article-title":"Cost effectiveness and screening interval of lipid screening in Hodgkin\u2019s lymphoma survivors","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026081003524966800_djag080-B13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jnci\/djz037","article-title":"Cost-utility of early breast cancer surveillance in survivors of thoracic radiation-treated adolescent Hodgkin lymphoma","volume":"112","author":"Furzer","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2026081003524966800_djag080-B14","doi-asserted-by":"publisher","first-page":"e024735","DOI":"10.1161\/JAHA.121.024735","article-title":"Underdiagnosis and undertreatment of modifiable cardiovascular risk factors among survivors of childhood cancer","volume":"11","author":"Chow","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026081003524966800_djag080-B15","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jacc.2015.04.013","article-title":"Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude Lifetime Cohort Study","volume":"65","author":"Armstrong","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026081003524966800_djag080-B16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaccao.2022.12.010","article-title":"Prevalence of diastolic dysfunction in adult survivors of childhood cancer","volume":"5","author":"Palmer","year":"2023","journal-title":"J Am Coll Cardiol CardioOncol"},{"key":"2026081003524966800_djag080-B17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/sj.bjc.6605215","article-title":"The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage","volume":"101","author":"Howell","year":"2009","journal-title":"Br J Cancer"},{"key":"2026081003524966800_djag080-B18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s11764-024-01561-y","article-title":"Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors","volume":"19","author":"Lammers","year":"2025","journal-title":"J Cancer Surviv"},{"key":"2026081003524966800_djag080-B19","first-page":"495","article-title":"The global burden of disease in 1990: summary results, sensitivity analysis and future directions","volume":"72","author":"Murray","year":"1994","journal-title":"Bull World Health Organ"},{"key":"2026081003524966800_djag080-B20","doi-asserted-by":"crossref","DOI":"10.1596\/0-1952-0890-0","volume-title":"World Development Report 1993: Investing in Health\u2013World Development Indicators","author":"World Bank","year":"1993"},{"key":"2026081003524966800_djag080-B21","doi-asserted-by":"crossref","first-page":"e74294","DOI":"10.1371\/journal.pone.0074294","article-title":"Development of methodology for disability-adjusted life years (DALYs) calculation based on real-life data","volume":"8","author":"Struijk","year":"2013","journal-title":"PLoS One"},{"key":"2026081003524966800_djag080-B22","doi-asserted-by":"crossref","first-page":"e55601","DOI":"10.2196\/55601","article-title":"Effectiveness and cost-effectiveness of survivorship care for survivors of Hodgkin lymphoma (INSIGHT Study): protocol for a multicenter retrospective cohort study with a quasi-experimental design","volume":"13","author":"Lammers","year":"2024","journal-title":"JMIR Res Protoc."},{"key":"2026081003524966800_djag080-B23","author":"The Netherlands Cancer Registry"},{"key":"2026081003524966800_djag080-B24","author":"Vektis"},{"key":"2026081003524966800_djag080-B25","author":"Statistics Netherlands"},{"key":"2026081003524966800_djag080-B26","author":"Statistics Netherlands. Causes of death"},{"key":"2026081003524966800_djag080-B27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12963-024-00347-9","article-title":"Standardised reporting of burden of disease studies: the STROBOD statement","volume":"22","author":"Devleesschauwer","year":"2024","journal-title":"Popul Health Metr"},{"key":"2026081003524966800_djag080-B28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2019","journal-title":"Lancet"},{"key":"2026081003524966800_djag080-B29","author":"Statistics Netherlands","year":"2023"},{"key":"2026081003524966800_djag080-B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12963-024-00342-0","article-title":"Deriving disability weights for the Netherlands: findings from the Dutch disability weights measurement study","volume":"22","author":"Haagsma","year":"2024","journal-title":"Popul Health Metr"},{"key":"2026081003524966800_djag080-B31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jnci\/djaf276","article-title":"Survivorship care and mortality in a contemporary and diverse cohort of childhood cancer survivors","volume":"118","author":"Ji","year":"2026","journal-title":"J Natl Cancer Inst"},{"key":"2026081003524966800_djag080-B32","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/eurjpc\/zwae174","article-title":"Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions","volume":"31","author":"Hageman","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026081003524966800_djag080-B33","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081003524966800_djag080-B34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026081003524966800_djag080-B35","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/jnci\/djp147","article-title":"Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma","volume":"101","author":"De Bruin","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026081003524966800_djag080-B36","author":"Tijn-A-Ton"},{"key":"2026081003524966800_djag080-B37","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1002\/cncr.34464","article-title":"Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma","volume":"128","author":"Krul","year":"2022","journal-title":"Cancer"},{"key":"2026081003524966800_djag080-B38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1667\/RR14888.1","article-title":"Hypothyroidism after radiation therapy for childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"190","author":"Inskip","year":"2018","journal-title":"Radiat Res"},{"key":"2026081003524966800_djag080-B39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/10428194.2021.1999445","article-title":"Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment","volume":"63","author":"Macklin-Doherty","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"2026081003524966800_djag080-B40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10096-009-0870-x","article-title":"Management of post-splenectomy patients in the Netherlands","volume":"29","author":"Lammers","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026081003524966800_djag080-B41","doi-asserted-by":"publisher","first-page":"e17302","DOI":"10.1371\/journal.pone.0017302","article-title":"Physicians report barriers to deliver best practice care for asplenic patients: a cross-sectional survey","volume":"6","author":"Lammers","year":"2011","journal-title":"PLoS One"},{"key":"2026081003524966800_djag080-B42","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s11764-023-01435-9","article-title":"A systematic review of smartphone applications for cancer survivors","volume":"18","author":"Changrani","year":"2024","journal-title":"J Cancer Surviv"},{"key":"2026081003524966800_djag080-B43","author":"Clinicaltrials.gov"},{"key":"2026081003524966800_djag080-B44","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.3324\/haematol.2023.283287","article-title":"Pilot study of lung cancer screening for survivors of Hodgkin lymphoma","volume":"109","author":"Broadbent","year":"2024","journal-title":"Haematologica"},{"key":"2026081003524966800_djag080-B45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00520-025-09605-4","article-title":"Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics","volume":"33","author":"Lammers","year":"2025","journal-title":"Support Care Cancer"},{"key":"2026081003524966800_djag080-B46","author":"BETER consortium. Participating Centers and Clinicians"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag080\/68076189\/djag080.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1514\/68076189\/djag080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1514\/68076189\/djag080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:52:55Z","timestamp":1786348375000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/8\/1514\/8653590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4,11]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag080","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,4,11]]}}}